{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:47:32Z","timestamp":1789832852536,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00234-023-03279-7","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T02:01:33Z","timestamp":1704506493000},"page":"317-323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Low rCBV values in glioblastoma tumor progression under chemoradiotherapy"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-603X","authenticated-orcid":false,"given":"A.","family":"Hilario","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cardenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lechuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Martinez de Aragon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Perez-Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hernandez-Lain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lagares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Toldos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Rodriguez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"key":"3279_CR1","doi-asserted-by":"publisher","unstructured":"Shukla G, Alexander GS, Bakas S et al (2017) Advanced magnetic resonance imaging in glioblastoma: a review. Chin Clin Oncol 6(4):40. https:\/\/doi.org\/10.21037\/cco.2017.06.28","DOI":"10.21037\/cco.2017.06.28"},{"issue":"11","key":"3279_CR2","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.crad.2015.06.096","volume":"70","author":"S Abdulla","year":"2015","unstructured":"Abdulla S, Saada J, Johnson G et al (2015) Tumor progression or pseudoprogression? A review of post-treatment radiological appearances of glioblastoma. Clin Radiol 70(11):1299\u20131312. https:\/\/doi.org\/10.1016\/j.crad.2015.06.096","journal-title":"Clin Radiol"},{"issue":"3","key":"3279_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M, van den Bent PM et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18(3):170\u2013186. https:\/\/doi.org\/10.1038\/s41571-020-00447-z","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"3279_CR4","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.354","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28(11):1963\u20131972. https:\/\/doi.org\/10.1200\/JCO.2009.26.354","journal-title":"J Clin Oncol"},{"key":"3279_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6828396","author":"A Zikou","year":"2018","unstructured":"Zikou A, Sioka C, Alexiou G et al (2018) Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas. Contrast Media Mol Imaging. https:\/\/doi.org\/10.1155\/2018\/6828396","journal-title":"Contrast Media Mol Imaging"},{"issue":"8","key":"3279_CR6","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s12094-017-1816-x","volume":"20","author":"PD Delgado-L\u00f3pez","year":"2018","unstructured":"Delgado-L\u00f3pez PD, Ri\u00f1ones-Mena E, Corrales-Garc\u00eda EM (2018) Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis. Clin Transl Oncol 20(8):939\u2013953. https:\/\/doi.org\/10.1007\/s12094-017-1816-x","journal-title":"Clin Transl Oncol"},{"issue":"10","key":"3279_CR7","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1007\/s00330-017-4789-9","volume":"27","author":"BRJ van Dijken","year":"2017","unstructured":"van Dijken BRJ, van Laar PJ, Holtman GA et al (2017) Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis. Eur Radiol 27(10):4129\u20134144. https:\/\/doi.org\/10.1007\/s00330-017-4789-9","journal-title":"Eur Radiol"},{"issue":"5","key":"3279_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459\u2013466. https:\/\/doi.org\/10.1016\/S1470-2045(09)70025-7","journal-title":"Lancet Oncol"},{"issue":"4","key":"3279_CR9","first-page":"859","volume":"27","author":"JL Boxerman","year":"2006","unstructured":"Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27(4):859\u2013867","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"3279_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/neuonc\/now148","volume":"19","author":"P Patel","year":"2017","unstructured":"Patel P, Baradaran H, Delgado D et al (2017) MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis. Neuro Oncol 19(1):118\u2013127. https:\/\/doi.org\/10.1093\/neuonc\/now148","journal-title":"Neuro Oncol"},{"issue":"5","key":"3279_CR11","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3174\/ajnr.A4218","volume":"36","author":"AJ Prager","year":"2015","unstructured":"Prager AJ, Martinez N, Beal K et al (2015) Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence. AJNR Am J Neuroradiol 36(5):877\u2013885. https:\/\/doi.org\/10.3174\/ajnr.A4218","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"3279_CR12","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1016\/j.crad.2014.01.016","volume":"69","author":"KE Shin","year":"2014","unstructured":"Shin KE, Ahn KJ, Choi HS et al (2014) DCE and DSC MR perfusion imaging in the differentiation of recurrent tumour from treatment-related changes in patients with glioma. Clin Radiol 69(6):e264-272. https:\/\/doi.org\/10.1016\/j.crad.2014.01.016","journal-title":"Clin Radiol"},{"issue":"1","key":"3279_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clinimag.2012.02.016","volume":"37","author":"RJ Young","year":"2013","unstructured":"Young RJ, Gupta A, Shah AD et al (2013) MRI perfusion in determining pseudoprogression in patients with glioblastoma. Clin Imaging 37(1):41\u201349. https:\/\/doi.org\/10.1016\/j.clinimag.2012.02.016","journal-title":"Clin Imaging"},{"issue":"1","key":"3279_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2214\/AJR.11.7417","volume":"198","author":"GM Fatterpekar","year":"2012","unstructured":"Fatterpekar GM, Galheigo D, Narayana A et al (2012) Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum\u2013use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI. AJR Am J Roentgenol 198(1):19\u201326. https:\/\/doi.org\/10.2214\/AJR.11.7417","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"3279_CR15","first-page":"901","volume":"21","author":"T Sugahara","year":"2000","unstructured":"Sugahara T, Korogi Y, Tomiguchi S et al (2000) Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 21(5):901\u2013909","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"3279_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jmri.26306","volume":"49","author":"BRJ van Dijken","year":"2019","unstructured":"van Dijken BRJ, van Laar PJ, Smits M et al (2019) Perfusion MRI in treatment evaluation of glioblastomas: clinical relevance of current and future techniques. J Magn Reson Imaging 49(1):11\u201322. https:\/\/doi.org\/10.1002\/jmri.26306","journal-title":"J Magn Reson Imaging"},{"issue":"9","key":"3279_CR17","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3174\/ajnr.A6685","volume":"41","author":"N Soni","year":"2020","unstructured":"Soni N, Ora M, Mohindra N et al (2020) Diagnostic performance of PET and perfusion-weighted imaging in differentiating tumor recurrence or progression from radiation necrosis in posttreatment gliomas: a review of literature. AJNR Am J Neuroradiol 41(9):1550\u20131557. https:\/\/doi.org\/10.3174\/ajnr.A6685","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"3279_CR18","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.acra.2021.11.008","volume":"29","author":"A Feng","year":"2022","unstructured":"Feng A, Yuan P, Huang T et al (2022) Distinguishing tumor recurrence from radiation necrosis in treated glioblastoma using multiparametric MRI. Acad Radiol 29(9):1320\u20131331. https:\/\/doi.org\/10.1016\/j.acra.2021.11.008","journal-title":"Acad Radiol"},{"issue":"3","key":"3279_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/neuonc\/noy133","volume":"21","author":"JY Kim","year":"2019","unstructured":"Kim JY, Park JE, Jo Y et al (2019) Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients. Neuro Oncol 21(3):404\u2013414. https:\/\/doi.org\/10.1093\/neuonc\/noy133","journal-title":"Neuro Oncol"},{"key":"3279_CR20","doi-asserted-by":"publisher","unstructured":"Hygino da Cruz LC Jr, Rodriguez I, Domingues RC et al (2011) Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol 32(11):1978-1985. https:\/\/doi.org\/10.3174\/ajnr.A2397","DOI":"10.3174\/ajnr.A2397"},{"issue":"6","key":"3279_CR21","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.rcl.2019.07.003","volume":"57","author":"SB Strauss","year":"2019","unstructured":"Strauss SB, Meng A, Ebani EJ et al (2019) Imaging glioblastoma posttreatment: progression, pseudoprogression, pseudoresponse, radiation necrosis. Radiol Clin North Am 57(6):1199\u20131216. https:\/\/doi.org\/10.1016\/j.rcl.2019.07.003","journal-title":"Radiol Clin North Am"},{"issue":"1","key":"3279_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.radonc.2015.12.017","volume":"118","author":"J Petr","year":"2016","unstructured":"Petr J, Platzek I, Seidlitz A et al (2016) Early and late effects of radiochemotherapy on cerebral blood flow in glioblastoma patients measured with non-invasive perfusion MRI. Radiother Oncol 118(1):24\u201328. https:\/\/doi.org\/10.1016\/j.radonc.2015.12.017","journal-title":"Radiother Oncol"},{"issue":"3","key":"3279_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/neuonc\/noac194","volume":"25","author":"A Seyve","year":"2023","unstructured":"Seyve A, Dehais C, Chinot O et al (2023) Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: a POLA network study. Neuro Oncol 25(3):495\u2013507. https:\/\/doi.org\/10.1093\/neuonc\/noac194","journal-title":"Neuro Oncol"},{"issue":"4","key":"3279_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/jcm10040598","volume":"10","author":"V Richter","year":"2021","unstructured":"Richter V, Klose U, Bender B et al (2021) Dynamic susceptibility perfusion imaging for differentiating progressive disease from pseudoprogression in diffuse glioma molecular subtypes. J Clin Med 10(4):598. https:\/\/doi.org\/10.3390\/jcm10040598","journal-title":"J Clin Med"},{"issue":"3","key":"3279_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11940-017-0445-6","volume":"19","author":"H Hyare","year":"2017","unstructured":"Hyare H, Thust S, Rees J (2017) Advanced MRI techniques in the monitoring of treatment of gliomas. Curr Treat Options Neurol 19(3):11. https:\/\/doi.org\/10.1007\/s11940-017-0445-6","journal-title":"Curr Treat Options Neurol"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-023-03279-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-023-03279-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-023-03279-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T16:23:14Z","timestamp":1708014194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-023-03279-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3279"],"URL":"https:\/\/doi.org\/10.1007\/s00234-023-03279-7","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,6]]},"assertion":[{"value":"5 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors have no financial or non-financial interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the studies involving human participants were in accordance with the ethical standards of institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}